Macrogen Inc (038290) - Net Assets

Latest as of September 2025: ₩168.36 Billion KRW ≈ $114.09 Million USD

Based on the latest financial reports, Macrogen Inc (038290) has net assets worth ₩168.36 Billion KRW (≈ $114.09 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩341.60 Billion ≈ $231.50 Million USD) and total liabilities (₩173.25 Billion ≈ $117.41 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset allocation strategy of Macrogen Inc to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩168.36 Billion
% of Total Assets 49.28%
Annual Growth Rate 11.5%
5-Year Change -10.46%
10-Year Change 133.11%
Growth Volatility 20.81

Macrogen Inc - Net Assets Trend (2011–2024)

This chart illustrates how Macrogen Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Macrogen Inc market cap and net worth.

Annual Net Assets for Macrogen Inc (2011–2024)

The table below shows the annual net assets of Macrogen Inc from 2011 to 2024. Also explore 038290 net assets growth trend to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2024-12-31 ₩177.43 Billion
≈ $120.24 Million		 +11.46%
2023-12-31 ₩159.19 Billion
≈ $107.88 Million		 -11.23%
2022-12-31 ₩179.32 Billion
≈ $121.52 Million		 -10.63%
2021-12-31 ₩200.64 Billion
≈ $135.97 Million		 +1.26%
2020-12-31 ₩198.15 Billion
≈ $134.28 Million		 +74.84%
2019-12-31 ₩113.33 Billion
≈ $76.80 Million		 -3.97%
2018-12-31 ₩118.01 Billion
≈ $79.98 Million		 +25.17%
2017-12-31 ₩94.28 Billion
≈ $63.89 Million		 +14.21%
2016-12-31 ₩82.55 Billion
≈ $55.94 Million		 +8.46%
2015-12-31 ₩76.11 Billion
≈ $51.58 Million		 +13.38%
2014-12-31 ₩67.13 Billion
≈ $45.49 Million		 +11.80%
2013-12-31 ₩60.05 Billion
≈ $40.69 Million		 +16.12%
2012-12-31 ₩51.71 Billion
≈ $35.05 Million		 +19.97%
2011-12-31 ₩43.11 Billion
≈ $29.21 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Macrogen Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 6685450379000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings ₩66.85 Billion 41.57%
Common Stock ₩5.42 Billion 3.37%
Other Components ₩88.55 Billion 55.06%
Total Equity ₩160.82 Billion 100.00%

Macrogen Inc Competitors by Market Cap

The table below lists competitors of Macrogen Inc ranked by their market capitalization.

Company Market Cap
LOT VACUUM Co. Ltd
KQ:083310
 $83.55 Million
Advanced Optoelectronic Technology Inc
TW:3437
 $83.57 Million
Quantum Graphite Ltd
AU:QGL
 $83.58 Million
Sao Ta Foods JSC
VN:FMC
 $83.60 Million
Gan Shmuel
TA:GSFI
 $83.52 Million
Choil Aluminum
KO:018470
 $83.50 Million
Dagi Giyim Sanayi ve Ticaret AS
IS:DAGI
 $83.50 Million
Byrna Technologies Inc
NASDAQ:BYRN
 $83.48 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Macrogen Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 159,190,685,230 to 160,823,227,140, a change of 1,632,541,910 (1.0%).
  • Net loss of 7,603,104,930 reduced equity.
  • Dividend payments of 2,991,692,100 reduced retained earnings.
  • Share repurchases of 49,739,940 reduced equity.
  • Other factors increased equity by 12,277,078,880.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ₩-7.60 Billion -4.73%
Dividends Paid ₩2.99 Billion -1.86%
Share Repurchases ₩49.74 Million -0.03%
Other Changes ₩12.28 Billion +7.63%
Total Change ₩- 1.03%

Book Value vs Market Value Analysis

This analysis compares Macrogen Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.83x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 1.32x to 0.83x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 ₩9296.03 ₩12300.00 x
2017-12-31 ₩10360.25 ₩12300.00 x
2018-12-31 ₩11778.45 ₩12300.00 x
2019-12-31 ₩11480.44 ₩12300.00 x
2020-12-31 ₩20306.42 ₩12300.00 x
2021-12-31 ₩20289.98 ₩12300.00 x
2022-12-31 ₩17860.79 ₩12300.00 x
2023-12-31 ₩15952.47 ₩12300.00 x
2024-12-31 ₩14834.18 ₩12300.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Macrogen Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -4.73%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -5.60%
  • • Asset Turnover: 0.41x
  • • Equity Multiplier: 2.05x
  • Recent ROE (-4.73%) is below the historical average (5.33%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2011 7.35% 9.69% 0.56x 1.35x ₩-1.13 Billion
2012 6.66% 7.76% 0.54x 1.60x ₩-1.72 Billion
2013 10.79% 13.42% 0.55x 1.47x ₩474.52 Million
2014 4.54% 5.60% 0.47x 1.74x ₩-3.65 Billion
2015 13.36% 12.79% 0.59x 1.76x ₩2.56 Billion
2016 5.21% 4.72% 0.57x 1.93x ₩-3.95 Billion
2017 10.11% 9.36% 0.57x 1.90x ₩101.06 Million
2018 2.24% 2.34% 0.63x 1.52x ₩-9.16 Billion
2019 -3.09% -2.86% 0.54x 1.99x ₩-14.83 Billion
2020 44.58% 78.45% 0.39x 1.45x ₩68.52 Billion
2021 0.55% 0.86% 0.43x 1.50x ₩-18.95 Billion
2022 -12.41% -16.05% 0.49x 1.56x ₩-40.18 Billion
2023 -10.56% -12.66% 0.52x 1.62x ₩-32.73 Billion
2024 -4.73% -5.60% 0.41x 2.05x ₩-23.69 Billion

Industry Comparison

This section compares Macrogen Inc's net assets metrics with peer companies in the Biotechnology & Medical Research industry.

Industry Context

  • Industry: Biotechnology & Medical Research
  • Average net assets among peers: $68,107,184,377
  • Average return on equity (ROE) among peers: -16.19%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Macrogen Inc (038290) ₩168.36 Billion 7.35% 1.03x $83.53 Million
Panagene Inc (046210) $8.91 Billion -7.07% 1.88x $24.44 Million
Cell Biotech Co. Ltd (049960) $84.15 Billion 21.98% 0.08x $82.66 Million
Bioneer Corporation (064550) $30.20 Billion -44.90% 1.23x $155.59 Million
MEDIPOST Co. Ltd (078160) $252.60 Billion -24.75% 0.64x $92.97 Million
Biotoxtech Co. Ltd (086040) $25.60 Billion 0.00% 0.81x $23.58 Million
Peptron Inc (087010) $7.18 Billion -42.42% 0.61x $1.63 Billion

About Macrogen Inc

KQ:038290 Korea Biotechnology & Medical Research
Market Cap
$83.53 Million
₩123.26 Billion KRW
Market Cap Rank
#19990 Global
#1048 in Korea
Share Price
₩12300.00
Change (1 day)
+1.23%
52-Week Range
₩10700.00 - ₩19520.00
All Time High
₩49726.89
Categories
Companies in Korea Biotechnology & Medical Research
About

Macrogen, Inc. provides genetic and genomic analysis research services in South Korea and internationally. It offers next generation sequencing (NGS) services, such as whole genome, exome, targeted, transcriptome, metagenome, epigenome, and single cell multi-omics sequencing, as well as whole genome resequencing; and standard, difficult template, and 16S/18S/26S rRNA and ITS region sequencing ser… Read more